Author
Dana-Farber Cancer InstituteORCID 0000-0003-0928-5244Unclaimed ORCID profile · follow to get notified of new preprints
5 papers
Recent·Most cited
Jake June-Koo Lee, Sohrab Salehi, Matthew A. Myers…·Sohrab P. Shah
The paper analyzes the evolutionary trajectories of high-level copy-number amplifications in cancer cell genomes to distinguish between extrachromosomal and intrachromosomal amplification mechanisms.
Aya Ludin, Georgia L. Stirtz, Asaf Tal…·Leonard Ira Zon
The paper identifies crater-shaped structures in melanoma that enhance immune response to checkpoint blockade therapy in humans and zebrafish.
James R. Lindsay, Jennifer Altreuter, Joao V. Alessi…·William E. Lotter
The paper provides a pan-cancer spatial analysis of immune biomarkers in the tumor microenvironment using multiplex immunofluorescence data from 2,019 tumors across 14 cancer types.
Stefan Groha, Sarah Abou Alaiwi, Wenxin Vincent Xu…·Alexander Gusev
This study identifies three germline variants associated with immune-related adverse events in patients treated with immune checkpoint inhibitors.
Arvind Ravi, Justin F. Gainor, Monica B. Arniella…·Matthew David Hellmann
This study identifies molecular and immune features associated with response to anti-PD-(L)1 therapy in NSCLC using a cohort of 393 patients.